89bio, Inc. Analytics - Traffic, Statistics and Competitor Tracking


89bio, Inc. Website Screenshot

http://www.89bio.com

89bio, Inc. Company Intro

89bio is a clinical-stage biopharmaceutical company focused on rapidly advancing our lead product candidate, BIO89-100, through clinical development for the treatment of non-alcoholic steatohepatitis (NASH). BIO89-100 is a specifically engineered glycoPEGylated analog of fibroblast growth factor 21 (FGF21). It may be a differentiated FGF21 therapy, and we believe it has the potential to become a mainstay of therapy for NASH given its ability to address the key liver pathologies (steatosis and fibrosis) and underlying metabolic dysregulation in patients with NASH. We are also expanding the breadth of indications for BIO89-100 with an initial focus on severe hypertriglyceridemia (SHTG).

Industry

Healthcare

89bio, Inc. Headquaters

142 Sansome Street
San Francisco,94104
United States


89bio, Inc. Share price

30 Oct 2020 01:35 GMT

$24.03

0.01 (0.04 %)


89bio, Inc. Market cap

$491.418 M


WMC RANKING

2020

89bio, Inc. # 473

Biotechnology

Latest 89bio, Inc. News

News 19 Oct 2020

Is 89bio Inc (ETNB) Stock a Great Value?

89bio Inc (ETNB) stock is up 60.44% since Friday, November 8, 2019 when ETNB began trading. , and the average rating from Wall Street analysts is a Strong ...

News 19 Oct 2020

Benzinga's Top Upgrades, Downgrades For October 19, 2020

At the end of the last trading period, 89bio closed at $23.73. JP Morgan initiated coverage on GoodRx Holdings Inc (NASDAQ: GDRX) with a Neutral rating. The ...

News 19 Oct 2020

Is 89bio Inc (ETNB) Stock a Great Value?

89bio Inc (ETNB) stock is up 60.44% since Friday, November 8, 2019 when ETNB began trading. , and the average rating from Wall Street analysts is a Strong ...


WMC Market Score


WMC Market to Revenue Score


89bio, Inc. Market Financials


Revenue, Expenses, Profit


Company Currency Revenue Expense Profit Market Cap WMC Sector Score
89bio, Inc. USD $0 $40,184 $-60,323 $491.418M 473
Regeneron Pharmaceuticals, Inc. USD $8,693,200 $4,965,400 $2,983,500 $59.132B 1
Alexion Pharmaceuticals, Inc. USD $5,536,800 $2,523,000 $846,100 $25.908B 2
Vertex Pharmaceuticals Incorporated USD $5,402,685 $2,634,428 $2,080,775 $53.919B 3
ALK-Abello A/S USD $3,350,000 $1,873,000 $49,000 $21.932B 4

Market Analytics


Company Search vs Top 4 Industry Competitors



Total 89bio, Inc. Social Followers vs Top 4 Industry Competitors



89bio, Inc. Post vs Top 4 Industry Competitors




89bio, Inc. WMC Market Score Calculations


Details Revenue Total Social Followers Total Social Posts Search Volume Digital Footprint Size Digital change (New Pages) WMC Market Score
89bio, Inc. 0 0 0 0 0 0 0
Regeneron Pharmaceuticals, Inc. 100 60.92 17.86 0 0 0 38.59
Alexion Pharmaceuticals, Inc. 63.69 13.39 100 78 0 0 93.46
Vertex Pharmaceuticals Incorporated 62.15 100 5 100 0 0 100
ALK-Abello A/S 38.54 0 0 0 0 0 0

Book a demo

Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.

* required fields

You'll learn how to:

  • 1. Automatically monitor your entire digital landscape including competitors
  • 2. View all new industry activity in real time
  • 3. Monitor your position in your industry
  • 4. Enrich your reports and strategy
  • 5. Empower your teams with knowledge

Our platform is loved & trusted by avariety
of world-leading brands

  • unilever
  • wavesight
  • acca
  • abeerdeen
  • UK2
  • umbo
  • rb
Industries